Related Experiment Video
Updated: May 9, 2025

Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
Evaluation of Treatment Response and Survival Outcomes in Anaplastic Thyroid Cancer Patients Following Surgery With
Hossein Negahban1, Nazila Heidari2,3, Amirhossein Heidari3,4
1Cancer Research Center of Cancer institute Tehran University of Medical Sciences Tehran Iran.
Background And Aims:
Anaplastic thyroid carcinoma (ATC) is a rare type of malignancy ranking among the most aggressive diseases globally, with an extremely poor prognosis. No optimal standardized treatment has been established yet to promote ATC's prognosis and increase the patients' median survival. We aim to assess the effectiveness of surgery alone or combined with other treatment approaches for ATC patients.
Methods:
PubMed, Web of Science, and Scopus databases were systematically searched until June 1st, 2023. Study selection was limited to English retrospective studies. A citation search was also performed for the final articles that were included. This study followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines for systematic reviews and meta-analyses.
Results:
During our search, we came to include 56 articles containing 16,246 patients suffering from ATC. We assessed the overall survival by treatment method and stage, emphasizing surgery's role. The most common efficacious treatment option in patients with resectable cancer is a combination of surgery with adjuvant chemoradiotherapy. However, surgery for stage IVC patients is controversial. Additionally, surgery and multimodality treatment can be affected by patients' characteristics, such as tumor size.
Conclusions:
Stage IVA and IVB resectable cancers may benefit from the combination of surgery and adjuvant therapies. However, the effectiveness of invasive treatments and the selection of appropriate adjuvant therapy options for IVC-stage patients are still controversial.
Insights
Surgery combined with adjuvant therapies offers benefits for resectable anaplastic thyroid carcinoma (ATC). However, optimal treatment for advanced stages (IVC) remains controversial, requiring further investigation for improved patient survival.
Area of Science:
- Oncology
- Surgical Oncology
- Thyroid Cancer Research
Background:
- Anaplastic thyroid carcinoma (ATC) is a rare, highly aggressive malignancy with a poor prognosis.
- Current treatment strategies lack standardization, hindering improvements in patient survival.
Purpose of the Study:
- To evaluate the effectiveness of surgical interventions, alone or in combination with other treatments, for anaplastic thyroid carcinoma.
Main Methods:
- Systematic review of retrospective English studies published until June 2023, indexed in PubMed, Web of Science, and Scopus.
- Adherence to PRISMA guidelines for systematic reviews and meta-analyses.
- Citation search of included articles.
Main Results:
- Analysis of 56 articles involving 16,246 ATC patients.
- Combination of surgery and adjuvant chemoradiotherapy is the most effective option for resectable ATC.
- Surgery's role in stage IVC ATC is debated, and treatment efficacy can be influenced by patient factors like tumor size.
Conclusions:
- Stage IVA and IVB resectable ATC may benefit from surgery plus adjuvant therapies.
- Treatment effectiveness and adjuvant therapy selection for stage IVC ATC remain controversial areas requiring further research.
More Related Videos
06:08Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
Published on: June 2, 2023
03:55Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
Related Concept Videos
Cancer Survival Analysis
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...